<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38508399</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7492</ISSN><JournalIssue CitedMedium="Internet"><Volume>344</Volume><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Virus research</Title><ISOAbbreviation>Virus Res</ISOAbbreviation></Journal><ArticleTitle>Can inflammatory plasma proteins predict Long COVID or Fatigue severity after SARS-CoV-2 infection?</ArticleTitle><Pagination><StartPage>199363</StartPage><MedlinePgn>199363</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">199363</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virusres.2024.199363</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0168-1702(24)00056-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To investigate whether specific immune response plasma proteins can predict an elevated risk of developing Long COVID symptoms or fatigue severity after SARS-CoV-2 infection.</AbstractText><AbstractText Label="METHODS">This study was based on 257 outpatients with test-confirmed SARS-CoV-2 infection between February 2020 and January 2021. At least 12 weeks after the acute infection, 92 plasma proteins were measured using the Olink Target 96 immune response panel (median time between acute infection and venous blood sampling was 38.8 [IQR: 24.0-48.0] weeks). The presence of Long COVID symptoms and fatigue severity was assessed 115.8 [92.5-118.6] weeks after the acute infection by a follow-up postal survey. Long COVID (yes/no) was defined as having one or more of the following symptoms: fatigue, shortness of breath, concentration or memory problems. The severity of fatigue was assessed using the Fatigue Assessment Scale (FAS). In multivariable-adjusted logistic and linear regression models the associations between each plasma protein (exposure) and Long COVID (yes/no) or severity of fatigue were investigated.</AbstractText><AbstractText Label="RESULTS">Nine plasma proteins were significantly associated with Long COVID before, but not after adjusting for multiple testing (FDR-adjustment): DFFA, TRIM5, TRIM21, HEXIM1, SRPK2, PRDX5, PIK3AP1, IFNLR1 and HCLS1. Moreover, a total of 10 proteins were significantly associated with severity of fatigue before FDR-adjustment: SRPK2, ITGA6, CLEC4G, HEXIM1, PPP1R9B, PLXNA4, PRDX5, DAPP1, STC1 and HCLS1. Only SRPK2 and ITGA6 remained significantly associated after FDR-adjustment.</AbstractText><AbstractText Label="CONCLUSIONS">This study demonstrates that certain immune response plasma proteins might play an important role in the pathophysiology of Long COVID and severity of fatigue after SARS-CoV-2 infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmitz</LastName><ForeName>Timo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Epidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany. Electronic address: timo.schmitz@med.uni-augsburg.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freuer</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Epidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Go&#xdf;lau</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Vascular Surgery, Faculty of Medicine, University of Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warm</LastName><ForeName>Tobias Dominik</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Vascular Surgery, Faculty of Medicine, University of Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyhlik-D&#xfc;rr</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vascular Surgery, Faculty of Medicine, University of Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linseisen</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Epidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meisinger</LastName><ForeName>Christa</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Epidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirchberger</LastName><ForeName>Inge</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Epidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virus Res</MedlineTA><NlmUniqueID>8410979</NlmUniqueID><ISSNLinking>0168-1702</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001798">Blood Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001798" MajorTopicYN="Y">Blood Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="Y">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Inflammatory protein markers</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>25</Day><Hour>0</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>21</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>20</Day><Hour>20</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38508399</ArticleId><ArticleId IdType="pmc">PMC10979265</ArticleId><ArticleId IdType="doi">10.1016/j.virusres.2024.199363</ArticleId><ArticleId IdType="pii">S0168-1702(24)00056-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Astin R., Banerjee A., Baker M.R., Dani M., Ford E., Hull J.H., Lim P.B., McNarry M., Morten K., O'Sullivan O., Pretorius E., Raman B., Soteropoulos D.S., Taquet M., Hall C.N. Long COVID: mechanisms, risk factors and recovery. Exp. Physiol. 2023;108(1):12&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Blundell S., Ray K.K., Buckland M., White P.D. Chronic fatigue syndrome and circulating cytokines: a systematic review. Brain Behav. Immun. 2015;50:186&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">26148446</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks D.L.P., Schwab L.P., Krutilina R., Parke D.N., Sethuraman A., Hoogewijs D., Sch&#xf6;rg A., Gotwald L., Fan M., Wenger R.H., Seagroves T.N. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models. Mol. Cancer. 2016;15:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4802728</ArticleId><ArticleId IdType="pubmed">27001172</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., van den Heede K. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann. Med. 2022;54(1):1473&#x2013;1487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti V., Corbi G., Sabbatino F., Pascale D.de, Sellitto C., Stefanelli B., Bertini N., Simone M.de, Liguori L., Di Paola I., Bernardo M.de, Tesse A., Rosa N., Pagliano P., Filippelli A. Long COVID: clinical Framing, Biomarkers, and Therapeutic approaches. J. Pers. Med. 2023;13(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9959656</ArticleId><ArticleId IdType="pubmed">36836568</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21(3):133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;n E., Yang C., Shannon C.P., Assadian S., He D., Tebbutt S.J. Cellular and molecular biomarkers of long COVID: a scoping review. EBioMedicine. 2023;91</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10082390</ArticleId><ArticleId IdType="pubmed">37037165</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu X., Wang S., Zhang W., Li C., Guo L., Wang Z., Li H., Zhang H., Zhou Y., Liang W., Li H., Liu Y., Wang Y., Huang L., Dong T., Zhang D., Wong C.C.L., Cao B. Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors. EBioMedicine. 2023;98</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10660018</ArticleId><ArticleId IdType="pubmed">37924708</ArticleId></ArticleIdList></Reference><Reference><Citation>Human Protein Atlas, 2014. https://www.proteinatlas.org/ENSG00000091409-ITGA6.</Citation></Reference><Reference><Citation>Jin H., Ying X., Que B., Wang X., Chao Y., Zhang H., Yuan Z., Qi D., Lin S., Min W., Yang M., Ji W. N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer. EBioMedicine. 2019;47:195&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6796523</ArticleId><ArticleId IdType="pubmed">31409574</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J.R., Dhodapkar R.M., Lu P., Gehlhausen J.R., Tabachnikova A., Greene K., Tabacof L., Malik A.A., Silva Monteiro V., Silva J., Kamath K., Zhang M., Dhal A., Ott I.M., Valle G., Pe&#xf1;a-Hern&#xe1;ndez M., Mao T., Bhattacharjee B., Takahashi T., Lucas C., Song E., McCarthy D., Breyman E., Tosto-Mancuso J., Dai Y., Perotti E., Akduman K., Tzeng T.J., Xu L., Geraghty A.C., Monje M., Yildirim I., Shon J., Medzhitov R., Lutchmansingh D., Possick J.D., Kaminski N., Omer S.B., Krumholz H.M., Guan L., Dela Cruz C.S., van Dijk D., Ring A.M., Putrino D., Iwasaki A. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623(7985):139&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimas N.G., Broderick G., Fletcher M.A. Biomarkers for chronic fatigue. Brain Behav. Immun. 2012;26(8):1202&#x2013;1210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373648</ArticleId><ArticleId IdType="pubmed">22732129</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovarik J.J., Bileck A., Hagn G., Meier-Menches S.M., Frey T., Kaempf A., Hollenstein M., Shoumariyeh T., Skos L., Reiter B., Gerner M.C., Spannbauer A., Hasimbegovic E., Schmidl D., Garh&#xf6;fer G., Gy&#xf6;ngy&#xf6;si M., Schmetterer K.G., Gerner C. A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome. iScience. 2023;26(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9719844</ArticleId><ArticleId IdType="pubmed">36507225</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung J.M., Wu M.J., Kheradpour P., Chen C., Drake K.A., Tong G., Ridaura V.K., Zisser H.C., Conrad W.A., Hudson N., Allen J., Welberry C., Parsy-Kowalska C., Macdonald I., Tapson V.F., Moy J.N., deFilippi C.R., Rosas I.O., Basit M., Krishnan J.A., Parthasarathy S., Prabhakar B.S., Salvatore M., Kim C.C. Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals. Front. Immunol. 2024;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10838987</ArticleId><ArticleId IdType="pubmed">38318183</ArticleId></ArticleIdList></Reference><Reference><Citation>Markov P.V., Ghafari M., Beer M., Lythgoe K., Simmonds P., Stilianakis N.I., Katzourakis A. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 2023;21(6):361&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">37020110</ArticleId></ArticleIdList></Reference><Reference><Citation>Meisinger C., Go&#xdf;lau Y., Warm T.D., Leone V., Hyhlik-D&#xfc;rr A., Linseisen J., Kirchberger I. Post-COVID-19 Fatigue and SARS-CoV-2 specific humoral and T-cell responses in male and female outpatients. Front. Immunol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9178094</ArticleId><ArticleId IdType="pubmed">35693828</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O'Hara M., Suett J., Dahmash D., Bugaeva P., Rigby I., Munblit D., Harriss E., Burls A., Foote C., Scott J., Carson G., Olliaro P., Sigfrid L., Stavropoulou C. Characterising long COVID: a living systematic review. BMJ Glob. Health. 2021;6(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Michielsen H.J., Vries J.de, van Heck G.L. Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment Scale. J. Psychosom. Res. 2003;54(4):345&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">12670612</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolakaki E., Sigala I., Giannakouros T. Good cop, bad cop: the different roles of SRPKs. Front. Genet. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9202992</ArticleId><ArticleId IdType="pubmed">35719374</ArticleId></ArticleIdList></Reference><Reference><Citation>Olink Proteomics  . Normalized Protein Expression. 2016. https://www.olink.com/faq/what-is-npx/</Citation></Reference><Reference><Citation>Paladino L., Vitale A.M., Caruso Bavisotto C., Conway de Macario E., Cappello F., Macario A.J.L., Gammazza A.M. The Role of Molecular Chaperones in Virus Infection and Implications for Understanding and Treating COVID-19. J. Clin. Med. 2020;9(11):3518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7693988</ArticleId><ArticleId IdType="pubmed">33143379</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponce-de-Leon M., Linseisen J., Peters A., Linkohr B., Heier M., Grallert H., Sch&#xf6;ttker B., Trares K., Bhardwaj M., G&#xe0;o X., Brenner H., Kami&#x144;ski K.A., Paniczko M., Kowalska I., Baumeister S.E., Meisinger C. Novel associations between inflammation-related proteins and adiposity: a targeted proteomics approach across four population-based studies. Translat. Res. 2022;242:93&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">34780968</ArticleId></ArticleIdList></Reference><Reference><Citation>Roerink M.E., van der Schaaf M.E., Dinarello C.A., Knoop H., van der Meer J.W.M. Interleukin-1 as a mediator of fatigue in disease: a narrative review. J. Neuroinflammation. 2017;14(1):16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5251329</ArticleId><ArticleId IdType="pubmed">28109186</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M., Sibilia J., Tsokos G.C., Gottenberg J.E. Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity. Clin. Immunol. 2023;248</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931423</ArticleId><ArticleId IdType="pubmed">36804225</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidbauer L., Kirchberger I., Go&#xdf;lau Y., Warm T.D., Hyhlik-D&#xfc;rr A., Linseisen J., Meisinger C. The association between the number of symptoms and the severity of Post-COVID-Fatigue after SARS-CoV-2 infection treated in an outpatient setting. J. Neurol. 2023;270(7):3294&#x2013;3302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10204671</ArticleId><ArticleId IdType="pubmed">37219607</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart R.L., West D., Wang C., Weiss H.L., Gal T., Durbin E.B., O'Connor W., Chen M., O'Connor K.L. Elevated integrin &#x3b1;6&#x3b2;4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer. Hum. Pathol. 2016;54:174&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4938774</ArticleId><ArticleId IdType="pubmed">27107458</ArticleId></ArticleIdList></Reference><Reference><Citation>Takada Y., Ye X., Simon S. The integrins. Genome Biol. 2007;8(5):215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1929136</ArticleId><ArticleId IdType="pubmed">17543136</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A., Vasaikar S.V., Szeto G.L., Lemos M.P., Czartoski J.L., MacMillan H., Moodie Z., Cohen K.W., Fleming L.B., Thomson Z., Okada L., Becker L.A., Coffey E.M., Rosa S.C.de, Newell E.W., Skene P.J., Li X., Bumol T.F., Juliana McElrath M., Torgerson T.R. Persistent serum protein signatures define an inflammatory subcategory of long COVID. Nat. Commun. 2023;14(1):3417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10252177</ArticleId><ArticleId IdType="pubmed">37296110</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol. Neurobiol. 2022;59(3):1850&#x2013;1861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., Huggins C.F., Kwong A.S.F., Silverwood R.J., Di Gessa G., Bowyer R.C.E., Northstone K., Hou B., Green M.J., Dodgeon B., Doores K.J., Duncan E.L., Williams F.M.K., Steptoe A., Porteous D.J., McEachan R.R.C., Tomlinson L., Goldacre B., Patalay P., Ploubidis G.B., Katikireddi S.V., Tilling K., Rentsch C.T., Timpson N.J., Chaturvedi N., Steves C.J. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 2022;13(1):3528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard, 2024: https://covid19.who.int/.</Citation></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect. Dis. (Lond) 2021;53(10):737&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Halim A., Halim M., Liu S., Aljeldah M., Al Shammari B.R., Alwarthan S., Alhajri M., Alawfi A., Alshengeti A., Khamis F., Alsalman J., Alshukairi A.N., Abukhamis N.A., Almaghrabi F.S., Almuthree S.A., Alsulaiman A.M., Alshehail B.M., Alfaraj A.H., Alhawaj S.A., Mohapatra R.K., Rabaan A.A. Inflammatory and vascular biomarkers in post-COVID-19 syndrome: a systematic review and meta-analysis of over 20 biomarkers. Rev. Med. Virol. 2023;33(2):e2424.</Citation><ArticleIdList><ArticleId IdType="pubmed">36708022</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>